Predict your next investment

HEALTHCARE | Biotechnology

See what CB Insights has to offer

About AgaPharm

AgaPharm is developing a prescription eye drop for Diabetics. The drug aims to offer a simple, low-cost treatment that can deliver a safe and effective dose to the eye, preventing or slowing down the onset of diabetic blindness and cataract. The company's Research Partner is the Biotechnology Research Institute at the National Research Council of the Government of Canada.

AgaPharm Headquarter Location

Ottawa, Ontario,


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing AgaPharm

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

AgaPharm is included in 1 Expert Collection, including Diabetes.



1,750 items

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.